Abstract
Background. This study was designed to identify the potassium-channel opener pinacidil as a cardioplegic agent vs hyperkalemic cardioplegia in terms of its efficacy in immature cardioprotection. Methods. By a Langendorff model, 21 hearts of 21- to 28-day-old New Zealand rabbits underwent 90 min of global hypothermic (15°C) ischemia protected with a different single dose of hypothermic (4°C) cardioplegia (pinacidil [50 μmol/l], St. Thomas’ solution combined with pinacidil [50 μmol/l], and St. Thomas’ solution). The percent recovery of the cardiac function, creatine kinase release, and cellular ultrastructure were compared. Results. Pinacidil (50 μmol/l) provided significantly the best postreperfused percentage recovery of the function than the other groups; pinacidil cardioplegia showed a significant reduction of creatine kinase release in the coronary flow compared with the other groups; St. Thomas’ solution combined with pinacidil showed the highest release. Percentage recovery of the coronary flow, water contents, and ultrastructural changes were similar between the groups. Conclusions. Pinacidil provided better protection during ischemia-reperfusion in the immature rabbit heart than St. Thomas’ solution, whereas pinacidil combined with St. Thomas’ solution showed the worst protective effects in immature hearts.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
